Quarterly report pursuant to Section 13 or 15(d)

Organization and Summary of Significant Accounting Policies (Details Narrative)

v3.24.1.1.u2
Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Jan. 30, 2024
Jan. 22, 2024
Mar. 31, 2024
Mar. 31, 2023
Jan. 21, 2024
Dec. 31, 2023
OrganizationLineItems [Line Items]            
Reverse stock split   1-for-20 reverse stock split        
Common stock, par value   $ 0.0001 $ 0.0001     $ 0.0001
Common stock shares issued   1,291,000 2,860,981   24,706,474 1,291,000
Common stock shares outstanding   1,286,000 2,855,981   24,606,474 1,286,000
Common stock shares authorized   100,000,000 100,000,000     100,000,000
Accumulated deficit     $ 78,095,462     $ 75,369,081
Net loss     2,726,381 $ 4,022,073    
Net cash for operating activities from continuing operations     2,048,884 2,114,070    
Net proceeds $ 6,300,000   6,282,430 $ 6,352,077    
Cash and cash equivalents     $ 8,920,363     $ 4,706,197
Purchase Agreement [Member]            
OrganizationLineItems [Line Items]            
Number of shares sold 476,000          
Net proceeds $ 6,300,000          
Purchase Agreement [Member] | Warrant [Member]            
OrganizationLineItems [Line Items]            
Warrants to purchase shares 1,555,555   1,617,777      
Purchase Agreement [Member] | Pre-Funded Warrants [Member]            
OrganizationLineItems [Line Items]            
Warrants to purchase shares 1,079,555          
Warrant exercised 1,079,555